Biomarkers as an opportunity to stratify for outcome in systemic sclerosis
Main Authors: | Giuseppina Abignano, Francesco Del Galdo |
---|---|
Format: | Article |
Language: | English |
Published: |
AVES
2020-10-01
|
Series: | European Journal of Rheumatology |
Online Access: | https://www.eurjrheumatol.org/en/biomarkers-as-an-opportunity-to-stratify-for-outcome-in-systemic-sclerosis-133322 |
Similar Items
-
Cardiovascular outcomes in systemic sclerosis with abnormal cardiovascular MRI and serum cardiac biomarkers
by: Maya H Buch, et al.
Published: (2021-11-01) -
Subclinical Systemic Sclerosis Primary Heart Involvement by Cardiovascular Magnetic Resonance Shows No Significant Interval Change
by: Raluca B. Dumitru, et al.
Published: (2023-02-01) -
Hypocomplementemia in systemic sclerosis
by: G. Valentini, et al.
Published: (2011-09-01) -
Downregulation of Vascular Hemeoxygenase-1 Leads to Vasculopathy in Systemic Sclerosis
by: Rebecca L Ross, et al.
Published: (2022-05-01) -
Hypocomplementemia in systemic sclerosis- author reply
by: G. Valentini, et al.
Published: (2011-06-01)